Stay updated on Efficacy of Nivolumab and Ipilimumab in Esophageal Cancer Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Nivolumab and Ipilimumab in Esophageal Cancer Clinical Trial page.

Latest updates to the Efficacy of Nivolumab and Ipilimumab in Esophageal Cancer Clinical Trial page
- Check5 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.1 to v3.7.2. The page otherwise continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check12 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedThe study record page now loads a 403 error instead of the trial details, indicating the page is inaccessible. This prevents users from viewing the study's design, eligibility, locations, and outcomes on that page.SummaryDifference18%

- Check54 days agoChange DetectedA 2016 U.S. NIH Grant/Contract entry was added, and the page revision was updated to Revision: v3.6.6 (replacing v3.6.5).SummaryDifference0.0%

- Check75 days agoChange DetectedThe page now displays a revision label of v3.6.5, replacing the previous v3.6.4. This indicates a new release or patch has been applied to the site.SummaryDifference0.0%

- Check89 days agoChange DetectedThe page revision updated from v3.6.3 to v3.6.4, representing a small maintenance update to the publication version of the entry. It does not reflect substantive changes to the study information.SummaryDifference0.0%

Stay in the know with updates to Efficacy of Nivolumab and Ipilimumab in Esophageal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Nivolumab and Ipilimumab in Esophageal Cancer Clinical Trial page.